Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope

Author： Marastoni M.   Bazzaro M.   Gavioli R.   Micheletti F.   Traniello S.   Tomatis R.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.35, Iss.6, 2000-06, pp. : 593-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite

Epstein-Barr virus and multiple sclerosis: association or causation?

By Pakpoor Julia   Giovannoni Gavin   Ramagopalan Sreeram V  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Epstein–Barr virus: novel patented therapeutics

By De Paoli Paolo  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 807-818

Informa Healthcare

Access to resources Recommend Favorite

Ciclosporin: Epstein-Barr virus-associated lymphoproliferative disorder: case report

By  

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Antineoplastics: Epstein-Barr virus lymphoproliferative disease in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1193, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite